Department of Oral Maxillofacial Head and Neck Oncology, 56695Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai China.
National Clinical Research Center of Oral Diseases, Shanghai, Shanghai China.
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211019511. doi: 10.1177/15330338211019511.
In this study, by comparing coplanar and noncoplanar intensity-modulated radiation therapy (IMRT) treatment planning in treating tongue cancer, the significance of noncoplanar fields in the protection of the lip and buccal mucosa was determined, and a reasonable solution was selected.
Forty-eight tongue cancer patients treated from June 2019 to February 2021 were selected and randomly divided into a coplanar field group and a noncoplanar field group. The mucosal dose limit changed from 15 Gy to 45 Gy for comparison of the two treatment plans. The evaluation indicators (conformal index (CI); homogeneity index (HI); D5, D50, and D98 of the target volume; and the dose of normal tissues) were calculated under different mucosal dose limits. The clinical observation of the lip and buccal mucosa of 48 cases was monitored and graded carefully according to NCI-CTCAE V4.0. Statistical analyses were performed.
The differences in CI, HI, D98, D50 and D5 between the two groups in the target volume tended to decrease when the mucosal dose limit was less than 30 Gy, with a significant difference ( < 0.05). When the limit exceeded 30 Gy, significant differences in other indicators except CI ( < 0.05) were still noted. In normal tissue, differences in doses between the two groups existed when the mucosal limit was less than 20 Gy, with a significant difference ( < 0.05). When the limit exceeded 20 Gy, no significant difference was noted. Patients in the noncoplanar group showed significantly better results than those in the other group in terms of the radiation-related toxicity of the lip and cheek membrane( < 0.001).
Compared with coplanar field radiotherapy, noncoplanar field radiotherapy can effectively reduce the exposure dose to the lip and buccal mucosa. The application of noncoplanar treatment plans exhibits good clinical significance and deserves to be promoted.
本研究通过对比平面和非平面调强放疗(IMRT)治疗舌癌的计划,确定非共面野在保护唇和颊黏膜方面的意义,并选择合理的解决方案。
选取 2019 年 6 月至 2021 年 2 月收治的 48 例舌癌患者,随机分为平面野组和非平面野组。将黏膜剂量限制从 15Gy 改为 45Gy,比较两种治疗计划。在不同黏膜剂量限制下,计算评价指标(适形指数(CI);均匀性指数(HI);靶区的 D5、D50 和 D98;正常组织剂量)。对 48 例唇颊黏膜进行临床观察,仔细按 NCI-CTCAE V4.0 分级。进行统计学分析。
当黏膜剂量限制小于 30Gy 时,两组靶区的 CI、HI、D98、D50 和 D5 差异趋于减小,差异有统计学意义(<0.05)。当限制超过 30Gy 时,除 CI 外,其他指标差异仍有统计学意义(<0.05)。在正常组织中,当黏膜限制小于 20Gy 时,两组之间的剂量存在差异,差异有统计学意义(<0.05)。当限制超过 20Gy 时,差异无统计学意义。非平面组患者在唇颊膜放射性毒性方面的结果明显优于其他组(<0.001)。
与平面野放疗相比,非平面野放疗能有效降低唇颊黏膜的受照剂量。非共面治疗计划的应用具有良好的临床意义,值得推广。